A000640 Stock Overview
Engages in the pharmaceutical business in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Dong-A Socio Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩94,800.00 |
| 52 Week High | ₩128,500.00 |
| 52 Week Low | ₩93,600.00 |
| Beta | 0.20 |
| 1 Month Change | -9.63% |
| 3 Month Change | -23.73% |
| 1 Year Change | -5.20% |
| 3 Year Change | -10.57% |
| 5 Year Change | -1.56% |
| Change since IPO | 198.00% |
Recent News & Updates
Recent updates
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Business Is Trailing The Market But Its Shares Aren't
Aug 13
Key Things To Watch Out For If You Are After Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) 0.8% Dividend
Apr 29These 4 Measures Indicate That Dong-A Socio Holdings (KRX:000640) Is Using Debt Extensively
Apr 08Are Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Mixed Financials Driving The Negative Sentiment?
Mar 18What Type Of Shareholders Own The Most Number of Dong-A Socio Holdings Co., Ltd. (KRX:000640) Shares?
Feb 25A Look At Dong-A Socio Holdings' (KRX:000640) Share Price Returns
Feb 04
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Jan 14Is It Smart To Buy Dong-A Socio Holdings Co., Ltd. (KRX:000640) Before It Goes Ex-Dividend?
Dec 24Dong-A Socio Holdings (KRX:000640) Takes On Some Risk With Its Use Of Debt
Dec 13Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Nov 22Shareholder Returns
| A000640 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -5.6% | -2.3% | 0.3% |
| 1Y | -5.2% | 11.7% | -1.5% |
Return vs Industry: A000640 underperformed the KR Pharmaceuticals industry which returned 12.5% over the past year.
Return vs Market: A000640 underperformed the KR Market which returned -0.2% over the past year.
Price Volatility
| A000640 volatility | |
|---|---|
| A000640 Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A000640 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A000640's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | n/a | Min-Young Kim | www.donga.co.kr |
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical trial to treat obesity; and STP0404 for the treatment of AIDS.
Dong-A Socio Holdings Co., Ltd. Fundamentals Summary
| A000640 fundamental statistics | |
|---|---|
| Market cap | ₩592.57b |
| Earnings (TTM) | ₩55.08b |
| Revenue (TTM) | ₩1.29t |
10.8x
P/E Ratio0.5x
P/S RatioIs A000640 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000640 income statement (TTM) | |
|---|---|
| Revenue | ₩1.29t |
| Cost of Revenue | ₩888.30b |
| Gross Profit | ₩400.35b |
| Other Expenses | ₩345.27b |
| Earnings | ₩55.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.81k |
| Gross Margin | 31.07% |
| Net Profit Margin | 4.27% |
| Debt/Equity Ratio | 57.7% |
How did A000640 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield25%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/17 03:59 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dong-A Socio Holdings Co., Ltd. is covered by 21 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ally Park | Citigroup Inc |
| Bora Chung | Daishin Securities Co. Ltd. |
| Jisoo Lee | DAOL Investment & Securities Co., Ltd. |